Professional
Staff
Fei
Lu, M.D., Chief Executive Officer
Dr.
Lu has five years of medical education and clinical practice
experience through Anhui Medical University in the P.R.
of China. She has over 15 years of experience in biochemical
and molecular biology techniques and has focused closely
on the development and growth of automated, large scale
sequencing projects. Much of her early experience in the
field of molecular biology was gained as a scientist in
the research labs at Baylor College of Medicine, Department
of Molecular and Human Genetics. Dr. Lu has published
extensively on topics in human molecular genetics. Since
1994, Dr. Fei Lu has been integral in the mobilization
of SeqWright to its current role as a leader in the field
of contract molecular biology services.
K.
Bradford Thomas, Ph.D., Bioinformatics Director
Dr.
Thomas received his B.S. degrees in Chemistry and Mathematics
from the University of Alabama. His Ph.D. in Pharmacology
was earned from the Emory University School of Medicine
in 1991. He has extensive experience in clinical molecular
genetics including analytical biochemical and molecular
genetic methods. Dr. Thomas directs the bioinformatics
aspects of all projects involving large-scale sequence
analysis and assembly.
Kristen M. Knezevich, ASQ-CQA, Director of Quality Assurance
Ms. Knezevich has over 15 years of experience in laboratory and biopharmaceutical Quality Assurance (QA). She performed QA functions in JCAHO and CAP regulated In Vitro Fertilization (IVF) laboratories at Johns Hopkins Hospital and Greater Baltimore Medical Center. Ms. Knezevich also directed compliance activities resulting in the CLIA certification of a physician office IVF laboratory. Good Laboratory Practice (GLP) and current Good Manufacturing Practice (cGMP) experience includes meeting the stringent requirements of major biopharmaceutical companies and international regulatory agencies at Cambrex Bio Science, Baltimore, Inc. and Lark Technologies. Ms. Knezevich is responsible for the Quality Assurance program and associated regulatory compliance activities in support of SeqWrights commitment to continuous quality improvement.
Ken Paynter, M.B.A. , Operations Manager
Dr.
Ken Paynter oversees SeqWright's production planning and business development initiatives. He joined SeqWright in 2001, in charge of laboratory process and customer support. Paynter holds an M.B.A. with a focus in Marketing and Management from the CT Bauer College of Business and a B.A. in Biology and Chemistry from Baylor University.
Scientific
Board
Richard
Gibbs, Ph.D., Founder
Dr.
Gibbs has been a pioneer in the development of novel
DNA sequencing methodologies and other genomics techniques.
Receiving a B.Sc. (Hons) and a Ph.D. in the area of
radiation biology at the University of Melbourne, Australia,
Dr. Gibbs subsequently moved to the United States for
further training. He has since acquired 20 years of
experience in the sequencing and genomics fields, and
now holds an appointment as a full Professor at Baylor
College of Medicine, where he serves as Director of
the Human Genome Sequencing Center.
John
W. Belmont, M.D., Ph.D., Founder
Dr.
Belmont is active as both a clinician and a research
scientist at Baylor College of Medicine. He serves as
an Associate Professor, with appointments in the departments
of Molecular and Human Genetics, Pediatrics, Microbiology
and Immunology. He is also founder and Co-Director of
the Cardiovascular Genetics Clinic at Texas Children's
Hospital. Dr. Belmont obtained a B.A. in Microbiology
from the University of Texas at Austin in 1974. He earned
his Ph.D. and M.D. degrees from Baylor College of Medicine
in 1980 and 1981 respectively. He maintains certification
by the American Board of Pediatrics and the American
Board of Medical Genetics. Dr. Belmont has published
extensively on topics in immunology, human genetic disorders,
and stem cell biology.
George
Weinstock, Ph.D., Scientific Director
Dr.
Weinstock received his Ph.D. from the Biology Department
at MIT and postdoctoral training in the Biochemistry
Department, Stanford University Medical School. He was
associated for four years with the Frederick Cancer
Research Facility, where he headed the DNA Metabolism
Section, Laboratory of Genetics and Recombinant DNA.
He became Co-Director of the Baylor College of Medicine
Human Genome Sequencing Center in 1998. Currently, his
work involves post-sequencing functional genomics and
informatics, as well as genome sequencing projects on
human, rat, and microbes.
|
